title: Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution.
authors.forename: D
authors.initials: D
authors.lastname: Montani
authors.forename: X
authors.initials: X
authors.lastname: Jaïs
authors.forename: P
authors.initials: P
authors.lastname: Dorfmuller
authors.forename: G
authors.initials: G
authors.lastname: Simonneau
authors.forename: O
authors.initials: O
authors.lastname: Sitbon
authors.forename: M
authors.initials: M
authors.lastname: Humbert
mesh_terms: D000077300:Bosentan; D005260:Female; D006439:Hemodynamics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage; D011654:Pulmonary Edema / Q000473:pathology; D015272:Pulmonary Medicine / Q000379:methods*; D011668:Pulmonary Veno-Occlusive Disease / Q000601:surgery / Q000628:therapy*; D011687:Purines / Q000008:administration & dosage; D012306:Risk; D000068677:Sildenafil Citrate; D013449:Sulfonamides / Q000008:administration & dosage; D013450:Sulfones / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
chemical_list: D010879:Piperazines; D011687:Purines; D013449:Sulfonamides; D013450:Sulfones; D000068677:Sildenafil Citrate; D000077300:Bosentan